Efficacy, safety and tolerability of oral sulphate tablet for bowel preparation in patients with inflammatory bowel disease: A multicentre randomized controlled study.

Kyeong Ok KimEun Young KimYoo Jin LeeHyun Seok LeeEun Soo KimYun Jin ChungByung Ik JangSung Kook KimChang Heon Yang

Published in: Journal of Crohn's & colitis (2022)

Both OST and 2 L PEG/Asc demonstrated high successful cleansing and safety in patients with inactive IBD. OST achieved higher satisfaction than 2 L PEG/Asc. Our results suggest that the OST split-dose regimen is effective and safe for patients with inactive IBD.

Keyphrases

double blind
patients with inflammatory bowel disease
open label
placebo controlled
drug delivery
clinical trial
nlrp inflammasome
study protocol
ulcerative colitis
randomized controlled trial
molecularly imprinted